Galactose-PEI–DNA complexes for targeted gene delivery: degree of substitution affects complex size and transfection efficiency
- 6 February 2003
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 88 (1) , 159-172
- https://doi.org/10.1016/s0168-3659(02)00458-3
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- DNA/polyethylenimine transfection particles: Influence of ligands, polymer size, and PEGylation on internalization and gene expressionAAPS PharmSci, 2001
- Size Reduction of Galactosylated PEI/DNA Complexes Improves Lectin-Mediated Gene Transfer into HepatocytesBioconjugate Chemistry, 1999
- Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transferGene Therapy, 1999
- Receptor-Mediated Gene Transfer to Cells of Hepatic Origin by Galactosylated Albumin-Polylysine Complexes.Biological & Pharmaceutical Bulletin, 1999
- The prospects of hepatic drug delivery and gene therapyExpert Opinion on Investigational Drugs, 1998
- The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cellsGene Therapy, 1998
- Increased liver uptake of liposomes and improved targeting efficacy by labeling with asialofetuin in rodentsHepatology, 1998
- In Vitro Gene Delivery to Hepatocytes with Galactosylated PolyethylenimineBioconjugate Chemistry, 1997
- Glycosylated Polylysine/DNA Complexes: Gene Transfer Efficiency in Relation with the Size and the Sugar Substitution Level of Glycosylated Polylysines and with the Plasmid SizeBioconjugate Chemistry, 1995
- Safety Considerations in Somatic Gene Therapy of Human Disease with Retrovirus VectorsHuman Gene Therapy, 1990